###### Strengths and limitations of this study

-   A strength of this study is its broad inclusion criteria that will allow the identification and subsequent standardisation of a large number of clinical indicators to be used as endpoints in clinical trials, thereby increasing the value and clinical applicability of perioperative research as part of the international Standardised Endpoints in Perioperative Medicine initiative.

-   A limitation of this study is that systematic review methodology only allows the identification and subsequent standardisation of existing clinical indicators rather than the development of novel indicators for future use.

-   A further limitation is that the literature search is limited to core clinical journals in order to retrieve the most clinically relevant and read publications.

-   Another potential limitation of this study is the exclusion of studies reporting clinical indicators before the year 2000.

-   A strength of this study is the broad range of cross-specialty clinicians participating in the Delphi process.

Introduction {#s1}
============

The drive to improve the quality of care provided in health systems around the world[@R1] has led to increased scrutiny in the measurement of patient outcomes. In order to inform local, national and international improvement initiatives, measurement and quantification of quality and safety of patient care are necessary.[@R2] Clinical safety and quality indicators provide clinicians, healthcare regulators and health funders with the means to both quantitatively and qualitatively describe healthcare performance.[@R3] They can, however, also be used in clinical trials in order to provide results that inform clinicians of best practice methods. For such purposes, it is important for clinical indicators to be consistent and reliable.

Developed initially in the manufacturing industry, indicators were first used in healthcare over three decades ago and have increasingly become used to monitor hospital organisational performance or patient care.[@R4] Indicators can be classified and are routinely described as relating to healthcare structure, process or outcome.[@R5] Structure indicators measure organisational resource utilisation and resilience, and are used to measure the quality of the setting in which care is delivered.[@R6] Structure indicators can be used to measure an institution's capacity to respond to the healthcare requirements of the population it serves. Examples may include funding allocations, staffing levels and access to equipment and facilities such as '24 hours access to a fully staffed emergency theatre'.

Process indicators allow us to measure the quality of delivery of care. They allow for the comparison of existing practice against standards of evidence based, best practice and are most commonly used to drive improvement initiatives.[@R6] Examples may include the timeliness of radiology reporting or seniority of operating surgeon. Outcome indicators are perhaps most familiar to clinicians and allow the measurement of the effects of health interventions on patients' health and well-being.[@R3] Traditionally, outcome indicators such as mortality and morbidity have been important to clinicians and patients. However, these outcome indicators are often poor discriminators of quality of care because of the broad range of potential confounders that may affect patient outcome.[@R3] A patient may experience poor outcomes despite exemplary care, or conversely, have excellent outcomes following low-quality care. As such, a much wider range of outcome indicators have been developed and are in use that describe a much broader set of clinical safety and quality outcomes.

Anaesthesia is a specialty that has safety at its heart. Perioperative medicine has evolved from anaesthesia out of a desire to improve outcomes for patients undergoing both elective and emergency surgery and perioperative research often uses quality and safety indicators as primary endpoints. A range of national quality improvement programmes have been developed within anaesthesia and perioperative medicine that use nationally measured structure, process and outcome indicators to drive local, institutional improvement. Examples include the National Emergency Laparotomy Audit[@R7] and the Perioperative Quality Improvement Programme[@R8] in the UK and the American College of Surgeons National Surgical Quality Improvement Programme[@R9] in the USA.

A search of the literature will reveal a plethora of clinical indicators used in healthcare that have been developed over the last three decades.[@R10] However, for a quality indicator to be useful, it must demonstrably lead to improved quality of care. There is considerable variation in the methods used to develop clinical indicators,[@R3] resulting in lack of consistency in the key attributes required of the ideal indicator, validity, reliability, applicability and relevance.[@R12]

In their 2017 systematic review, Chazapis *et al* identified 261 structure and process indicators in perioperative care.[@R13] Notably, they found that the majority of indicators in use had none or very little supporting evidence beyond face validity (expert opinion). Haller *et al* identified 108 clinical indicators available for quality and safety measurement in anaesthesia care alone.[@R14] Patient safety (83%) and effectiveness (68%) were the two dimensions most often addressed by these clinical indicators. However, only 40% of these clinical indicators also had a level of validity beyond face validity and many of them had inconsistent definitions across publications or in different national programmes. For instance, according to the Australian Council on Healthcare Standards, an unplanned admission to the intensive care unit was defined as 'an unplanned admission to the intensive care unit within 24 hours of a procedure with an anaesthetist in attendance' whereas the Anaesthesia Quality Institute (USA) defined it as 'an unplanned admission to the intensive care unit within 48 hours of induction'.[@R15]

As a result of this lack of consensus in defining clinical indicators across systems and countries, it becomes difficult to assess clinical performance and benchmark quality across hospitals. When considering the use of clinical indicators to report effectiveness of patient quality and safety improvement initiatives in health services research, an additional issue arises: the limited academic interest in clinical indicators. Consequently, these measurement tools are not always clearly identified and defined.[@R17] Such heterogeneity and lack of precise definitions limit the applicability of perioperative research by hindering our ability to compare, contrast and combine study data in order to identify the best evidence-based practice.[@R18]

Therefore, there exists a pressing need to define with greater precision and consistency clinical indicators that can be used as endpoints in perioperative clinical trials, particularly those that assess quality and safety improvement initiatives.[@R18]

The 'Standardised Endpoints for Perioperative Medicine' (StEP) initiative is an international, multidisciplinary collaborative dedicated to the identification and standardisation of a broad range of endpoints used for research and quality improvement perioperative medicine.[@R19] It aims to develop precisely defined, clinically valid and internationally applicable perioperative endpoints. A number of endpoint-specific subgroups of subject matter experts have been convened to use Delphi methods to explicitly define each endpoint. The 'clinical indicators' subgroup members are tasked with developing a set of consensus-based definitions for clinical indicators commonly used in the perioperative literature. It has the following objectives:To identify clinical indicators and their definitions used in randomised controlled trials that assess patient-related quality and safety interventions in perioperative medicine.To select, following an expert-based consensus-gaining process (Delphi method), a shortlist of recommended indicators and definitions that are the most suitable for the evaluation of quality and safety interventions.To provide a classification scale for each indicator related to its clarity of definition, validity (strength), reliability, feasibility (ease of use) and frequency of use.

By standardising the evidence base for assessing quality improvement initiatives, there may be more uniform adoption of these definitions as clinical indicators by national governments and payers in different countries.

Methods and analysis {#s2}
====================

The standard method developed by the University of California and the American Institute of research and development will be used.[@R20] A systematic review of the literature will be followed by the consensus opinion of a committee of experts. This approach has been adapted to facilitate the development and validation of clinical indicators and is divided into three different steps.

Step 1: systematic review of the literature {#s3}
===========================================

The first step will be to identify potential indicators. This will be done by an extensive and systematic review of the existing literature on perioperative care using strict definitions ([box 1](#B1){ref-type="boxed-text"}).Box 1Definitions used in the studyPerioperative careAll aspects of anaesthesia and perioperative care in adults other than the surgery itself. Specifically, obstetrics, pain and critical care can be included if they overlap with anaesthesia care but not if there is no perioperative or anaesthetic element.Quality improvement interventionAny intervention implemented at the level of a practice, hospital, health system or region, intended specifically to improve either the quality or the safety of care. The intervention includes the implementation of best medical practices, as defined locally or available through the best practice guidelines or protocols.Clinical indicatorAn explicit measure (defined by the developer) of some aspect of patient clinical care used to judge a particular clinical situation and measure the quality of the care delivered.[@R6]Outcome indicatorsPatient-related end results of anaesthesia and perioperative care according to Donabedian's framework and definition of quality of care.[@R5]Quality of careThe degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with the current professional knowledge.[@R30]

Eligibility criteria {#s3a}
--------------------

### Participants/population {#s3a1}

Only randomised controlled trials, quasi-experimental trials or before--after studies that report interventions to improve patient-related quality and safety of care within the perioperative context in adults \>18 years old will be included. Furthermore, only studies published between 1 January 2000 and 30 March 2016 in core clinical journals as defined by the National Library of Medicine[@R22] will be included.

### Interventions and comparators {#s3a2}

Interventions will include those implemented at the level of a practice, hospital, health system or region, intended specifically to improve either the quality or the safety of care. Interventions will include the implementation of best medical practices, as defined locally or available through best practice guidelines or protocols.

### Outcomes {#s3a3}

To be considered, the study will also need to use one or several clinical indicators as a measure of intervention effectiveness (outcome indicators). To be considered as a clinical indicator, the outcome measured needs to be an explicit measure of some aspect of patient clinical care (ie, safety, effectiveness) and will be used to judge a particular clinical situation and measure the quality of the care delivered by a healthcare provider.

### Setting {#s3a4}

We will consider studies from all settings, including high-income and low-income and middle-income countries.

### Patient and public involvement {#s3a5}

This study is non-clinical in nature, and therefore, patient and public involvement was not sought in the study design.

Exclusion criteria {#s3b}
------------------

We will exclude trials that assess drug, device or new procedure effectiveness and those that report adverse events as secondary outcomes. Studies that use patient comfort measures (pain, Post operative nausea and vomiting, sedation, immobility), patient-reported outcome measures (quality of life, return to work, functional assessment, satisfaction) and cost-related measures as clinical indicators will also be excluded. Studies that use indicators related exclusively to intensive care or surgical care will be excluded. These measures will be reviewed by other StEP subgroups.

Information sources {#s3c}
-------------------

The initial literature search will be performed to retrieve all clinical indicators exclusively from clinical trials. Database searches will be performed of Medline (PubMed/OVID), EMBASE and the Cochrane Library. The reference lists of retrieved articles will also be searched. If definitions of indicators in retrieved studies are incompletely defined, additional searches will be performed using web of science for abstracts of conferences, Google Scholar, professional organisations and quality improvement initiatives websites (grey literature) to retrieve original definitions of those indicators.

### Search strategy {#s3c1}

The literature search will be performed separately by two reviewers and specialised librarians. Results will be compared and integrated during a consensus meeting.

Search criteria will include a predefined list of clinical indicators extracted from systematic reviews and consensus statement papers on clinical indicators in perioperative care ([box 1](#B1){ref-type="boxed-text"}) and will be combined with various search terms related to quality and safety improvement initiatives, for example, \[unplanned ICU admission \[All Fields\] AND/OR (\" patient safety\"\[MeSH Terms\] OR 'quality of care'\[All Fields\] OR 'quality improvement '\[All Fields\]). Limits will then be applied to restrict retrieved articles to 'clinical trials' in 'core clinical journals'\].

The search will cover the period between January 2000 and March 2016. A complementary handsearch of the reference lists of retrieved articles will be performed for additional citations. We will also use observational studies and grey literature to complete definitions not available in the literature search. We will apply no language restriction. Authors of original articles will be contacted if study definitions of clinical indicators used are unclear or relevant data are missing. Detailed search strategy is available in online [supplementary appendices 1 and 2](#SP1 SP2){ref-type="supplementary-material"}.

Step 2: study selection and data extraction {#s4}
===========================================

The second phase will include the selection of articles and indicator programmes for data abstraction and quality rating.

Study selection, data management and data extraction process {#s4a}
------------------------------------------------------------

Two authors will independently screen titles, abstract contents and full article contents to exclude citations unrelated to the study topic, using other types of outcome measurement, being non-randomised trials or published in non-core clinical journals. For the selection process, Microsoft Endnote will be used and definitions provided in [box 1](#B1){ref-type="boxed-text"} will be used.

Data extraction {#s4b}
---------------

Following study selection, a full analysis of the selected articles will be performed independently by two authors. These will be analysed and data will be extracted according to a standardised extraction and coding template ([table 1](#T1){ref-type="table"}) with predefined categories and will include seven different categories:

###### 

Data extraction framework

  --------------------------------------- --------------------------------- ------------------------------------------ ---------------------------------------------------------------------------------------------------------- ------------ ---------------------------------------------------- --------------------
  Indicator's abbreviated/standard name   Developer's definition/criteria   Clarity (definition provided) 0=no 1=yes   Validity as a measure of quality and safety (0=no validity 1=intermediate validity 3=excellent validity)   References   Other indicators not defined or secondary outcomes   Additional details
  --------------------------------------- --------------------------------- ------------------------------------------ ---------------------------------------------------------------------------------------------------------- ------------ ---------------------------------------------------- --------------------

1.  Indicator's abbreviated/standard name.

2.  Author's definition.

3.  Indicator's clarity (definition provided) 0=no 1=yes.

4.  Validity as a measure of quality and safety (0=no validity 1=intermediate validity 3=excellent validity)
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1.  Study references.

2.  Other indicators not defined or secondary outcomes in the study.

3.  Additional details.

Redundant clinical indicators will be aggregated and composite measures excluded. The overall process will be performed by two assessors during a consensus meeting. Both are medical doctors with health services research training and/or anaesthesia specialty training. Any disagreement between the two reviewers will be resolved by discussion until a consensus between the two assessors has been reached.

Risk of bias will not be assessed as the purpose of this review is not to assess the effectiveness of any clinical information, but instead to identify the scope, definitions and validity of clinical indicators currently in use. Similarly, quantitative data synthesis or meta-analysis will not be performed.

Step 3: Delphi consensus process {#s5}
================================

The purpose of the third step is to gain a consensus around the validity of each indicator as a measure of patient quality in perioperative care («face validity») and consensus definitions to be used later in clinical trials.

During the third phase, the final shortlist of retrieved clinical indicators and associated definitions will be provided to members of the StEP initiative steering committee, subgroup coordinators and members. This represents a group of experts from surgery, intensive care and different anaesthesia specialties across different countries (Australia, Canada, The Netherlands, UK, USA, South Africa, Senegal and Switzerland). We will ask for their opinion regarding the indicators' validity as measures of quality, using the Delphi method.[@R23] This method aims to establish a consensus around an issue or a definition using successive questionnaires.

The Delphi method has the advantage of allowing each individual expert to provide their own individual opinion and thus avoid the common issues (ie, Hawthorne effect; influence of opinion leaders) associated with traditional consensus conferences.

Delphi round 1 {#s5a}
--------------

Following discussion with subgroup members, the theme subgroup chair will prepare the initial list of endpoints and associated definitions retrieved from the literature according to a predefined format prepared by the StEP steering committee ([table 1](#T1){ref-type="table"}). This initial list will be cross-checked for consistency and usability by another member of the theme subgroup (SB). The list will then be sent to all members of the clinical indicators' subgroup and the StEP steering committee in a process facilitated by the National Institute of Academic Anaesthesia (NIAA) Health Services Research Centre (HSRC).

Participants will be asked to score each of the indicators listed for clinical importance and clarity of definition using a scale of 1--9. If they consider the indicator and associated definition to not be useful or important, they will assign the labels 1--3 'not that important or invalid'. If participants consider the indicator to be useful or important but requiring improved definition and specification, they will assign the labels 4--6 'important but requires revision'. In contrast, if the indicator is seen as crucial and well defined, participants will assign the label between 7 and 9 'critical for inclusion'. Participants will be given the option to select 'not applicable/not sure' if they are unable to offer an opinion as to whether the item is important or not.

Participants will be allowed 2 weeks for task completion. A reminder email will be sent to prompt completion of the survey. The final number of respondents will be recorded (and later reported).

For each indicator, participants will be also invited to add any other endpoints, definitions or modifications to existing definitions that they believe to be important when conducting clinical trials that use quality and safety indicators. This will be possible by adding a comment in the 'comments or suggestions for this endpoint or choice of scale' section of the initial list ([table 1](#T1){ref-type="table"}). All answers will be sent back to the HSRC (via website or email---instructions to follow). The HSRC will be responsible for scoring the initial questionnaire using mean, median and range of scores and also collate all comments and suggestions provided by participants.

Delphi round 2 {#s5b}
--------------

The theme subgroup chair will systematically select indicators that have been rated as 'critical' (score ≥7) by at least 70% of participants (score 70% percentile ≥7) for the second round Delphi process. In contrast, indicators rated as 'not that important or invalid' (score ≤3) by at least 70% of participants (score 70% percentile ≤3) or as 'important but requiring revision' (score 70% percentile between \>3 and \<7) will be included for the second round only if suggested by any of the member of subgroup or the StEP working group. Additional endpoints or suggested modified definitions will also be discussed at this stage of the Delhi process.

The list of clinical indicators will be carried forward to the Delphi second round. This stage will include the entire StEP working group. This will be done with the help of the HSRC.

For this second round, participants will be provided with the number of respondents and scores for each selected item following round 1 in the 'critical' (score ≥7) category. They will be asked to consider the responses from other Delphi participants and to rescore the item using the same original questionnaire ([table 2](#T2){ref-type="table"}). A second list of indicators rated as 'not that important or invalid' (score ≤3) or as 'important but requiring revision' (score 70% percentile between \>3 and \<7) will be provided to the entire StEP working group including suggestions made by email and participants invited to rate these indicators only if considered as critical by any group member. Responses will be collected and sent to the subgroup chair by the HSRC.

###### 

Delphi round 1 and 2 format: example of absence of falls following surgery

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Endpoint and\                                                             Not that important or invalid   Important but requires revision   Critical for inclusion   NA or not sure   Score                      
  definition                                                                                                                                                                                                       
  ------------------------------------------------------------------------- ------------------------------- --------------------------------- ------------------------ ---------------- ------- --- --- --- --- -- --
                                                                            1                               2                                 3                        4                5       6   7   8   9      

  1\. Absence of falls following surgery\                                                                                                                                                                          
  Definition: absence of falls (any documented fall during hospital stay)                                                                                                                                          

  Rating                                                                                                                                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA, not applicable.

Delphi round 3 {#s5c}
--------------

The theme subgroup chair will only select indicators that have been rated as 'critical' (score ≥7) by at least 70% of participants (score 70% percentile ≥7) for the third round Delphi stage. Indicators rated as 'not that important or invalid' (score ≤3) or 'important but requiring revision' (score between \>3 and \<7) will not be included unless at this stage any participant suggests it should still be included in the third round. If responses to the second stage Delphi process suggest that modification to endpoint definitions or rating has to be made, this will be resolved within the indicator's theme subgroup via email discussion for the third stage of the Delphi process.

The questionnaire for the third stage of the Delphi process will be sent with the assistance of the NIAA HSRC to all members of the clinical indicators' subgroup and the StEP steering committee. For this third round, participants will be provided with the number of respondents and scores for each selected item following round 2. They will be asked to consider the responses from other Delphi participants and score the item using a second questionnaire ([table 3](#T3){ref-type="table"}).

###### 

Absence of falls following surgery

  Questions                                          No   Unsure   Yes   NA                  
  -------------------------------------------------- ---- -------- ----- ---- -- -- -- -- -- --
  Is this indicator valid?                                                                   
  Is this indicator reliable?                                                                
  Is this indicator easy to use?                                                             
  Is this indicator definition easy to understand?                                           
  Comment                                                                                    

Definition: absence of falls (any documented fall during hospital stay).

NA, not applicable.

The questionnaire includes four rating criteria per indicator[@R25]:Validity---The degree to which the indicator measures what it purports to measure.Reliability---The degree of stability of the indicator when measurement is repeated under identical conditions.Feasibility---Practicability/ease of use in the clinical context.Clarity of the definition---The degree to which the clinical indicator meaning can be easily understood.

For each question, participants will be asked to rate the indicator on a 1--9 scale with scores between 1 and 3 meaning 'no', 4--6 meaning 'unsure', 7--9 meaning 'yes'. Score 10 is not assessable. Details are provided in [table 3](#T3){ref-type="table"}.

At the end of the third Delphi round, indicators that have a score between 7 and 9 ('yes') for each question will be automatically selected as recommended indicators for quality measurement in clinical trials. Those that have been rated as 4--6 ('unsure') for one or several of the four rating criteria will be discussed by email within the indicator's subgroup. Those that have a score between 1 and 3 ('no') for any of the rating criteria will not be recommended, but still provided as a possible option for researchers. If responses to this final stage suggest that modification to endpoint definitions or rerating has to be conducted, this will also be resolved within the indicator's theme subgroup via email discussion.

Expected results {#s5d}
----------------

The systematic review will provide a hierarchical long-list of candidate endpoints with an associated rating for each clinical indicator. This will be followed by a shortlist of selected indicators and consensus definitions according to expert opinion. It will also provide researchers with a validity, reliability, feasibility and clarity rating and recommendations of use for indicators in quality improvement trials.

Ethics and dissemination {#s5e}
------------------------

Results of this StEP consensus-forming process to provide recommended indicators and definitions will be presented at national and international conferences, as well as published in peer-reviewed journals. It will provide both researchers and important healthcare system stakeholders with valid and consensus indicators and definitions to be used both in clinical trials and in quality improvement initiatives.

Discussion {#s6}
==========

This paper describes the protocol of a systematic review and associated Delphi process designed to identify, select and assess the most valid and suitable clinical indicators to be used for the assessment of quality and safety interventions.

There is currently a large number of clinical indicators with various and sometimes conflicting definitions that hinder their use for the assessment of perioperative care and more extensively, health services research. This heterogeneity also has an impact on the generation of scientific evidence that can guide clinical practice. In particular, clinical trials in the perioperative area can sometimes provide different conclusions owing to significant variability in outcome definitions.[@R27] This may reduce the applicability of this research to everyday practice. This systematic review and consensus-gathering process is part of the international StEP collaboration and is an important step in the process of identifying and standardising clinical indicators to be used as health service research and quality improvement endpoints.

A limitation of this study is that the current methodology does not allow for the definition or development of novel indicators for future use as endpoints in perioperative trials. Because it is based on a systematic review, the current method allows only for the appraisal and standardisation of existing indicators. An alternative method could be to first identify broad areas of academic and clinical interest and then embark on an attempt to define indicators in current use in these areas, and indicators for future use. However, an advantage of the chosen method for our study is that indicators for which consensus definitions are achieved will be immediately available, enabling researchers and clinicians to derive more value and applicability from findings of published perioperative research.

Another limitation is that clinical indicators can be sometimes confused with the broader outcome measures often used in clinical trials, especially when they relate to postoperative complications (ie, respiratory failure, acute postoperative myocardial infarct). This may lead to an extensive literature search with a large number of outcomes retrieved that lack the specificity for quality and safety measurement. This is why we will use broad, but strict inclusion criteria and select only randomised controlled trials, quasi-experimental trials or before--after studies that report interventions to improve patient-related quality and safety of care within the perioperative context.

Another limitation is that the purpose of the StEP international initiative is to identify and provide straightforward, clinically sensible and valid consensus definitions for a comprehensive set of trial endpoints[@R28] and as a result, there is a risk of overlap between the different outcomes identified by the different subgroups participating in the StEP international initiative. This is particularly true for outcomes related to postoperative complications (eg, aspiration), where they may be interpreted as conventional research outcome measures, but they also relate to quality and safety. This may bring some confusion as to which subgroup should deal with some outcomes (eg, the quality and safety indicator subgroup or the respiratory outcome subgroup). This may also add complexity to the consensus-gathering process as to which group should provide the definitive consensus definition. This will be resolved by discussion between subgroup chairs to decide which group should deal with overlapping measures.

Finally, the literature search is limited to core clinical journals. While this approach increases the likelihood of retrieving the most clinically relevant and read publications, it also limits the scope of the literature search process.

Once complete, the study will be published in a peer-reviewed journal. The aim of this study and the StEP initiative is to disseminate these standardised endpoints to the anaesthesia and perioperative medicine clinical and academic community to use in clinical trials and to inform clinical practice. This will be achieved through presentation at national and international conferences, and through publication in peer-reviewed journals.

Conclusion {#s7}
==========

Identifying standardised endpoints for quality and safety measurement should improve the consistency of perioperative clinical indicators used in research and quality improvement, and also therefore the reliability of their results. This should translate into improved interpretation of study results and better translation into clinical practice.
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